MORGAN SARAF: Open Payments
NPI 1295564987 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 79 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $359 · 2025 $1,596
Food & beverage: $1,596
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $258 |
| ABBVIE INC. | 15 | $236 |
| Novo Nordisk Inc | 12 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| PFIZER INC. | 4 | $86 |
| Abbott Laboratories | 3 | $72 |
| Exact Sciences Corporation | 3 | $70 |
| Edwards Lifesciences Corporation | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
Products named: ZEPBOUND, UBRELVY, Kerendia, CAPLYTA, JARDIANCE, MOUNJARO, FREESTYLE LIBRE 3, Wegovy.
Industry payments across NY — which companies pay providers there.
